Related Experiment Video
Updated: Jul 8, 2025
Author Spotlight: Minimally Invasive Relief for Occipital Neuralgia at the Nuchal Line
Published on: September 13, 2024
Refractory occipital neuralgia treatment with nerve decompression surgery: a case series
William G Austen1, Katya Remy1, Kathryn Packowski1
1Division of Plastic and Reconstructive Surgery, Massachusetts General Hospital, Boston, MA, United States.
Background:
The management of refractory occipital neuralgia (ON) can be challenging. Selection criteria for occipital nerve decompression surgery are not well defined in terms of clinical features and best preoperative medical management.
Methods:
In total, 15 patients diagnosed with ON by a board-certified, fellowship-trained headache specialist and referred to a plastic surgeon for nerve decompression surgery were prospectively enrolled. All subjects received trials of occipital nerve blocks (NB), at least three preventive medications, and onabotulinum toxin (BTX) prior to surgery before referral to a plastic surgeon. Treatment outcomes included headache frequency (headache days/month), intensity (0-10), duration (h), and response to medication/injectable therapies at 12 months postoperatively.
Results:
Preoperatively, median headache days/month was 30 (20-30), intensity 8 (8-10), and duration 24 h (12-24). Patients trialed 10 (±5.8) NB and 11.7 (±9) BTX cycles. Postoperatively, headache frequency was 5 (0-16) days/month (p < 0.01), intensity was 4 (0-6) (p < 0.01), and duration was 10 (0-24) h (p < 0.01). Median patient-reported percent resolution of ON headaches was 80% (70-85%). All patients reported improvement of comorbid headache disorders, most commonly migraine, and a reduction, discontinuation, or increased effectiveness of medications, NB and BTX.
Conclusion:
All patients who underwent treatment for refractory ON by a headache specialist and plastic surgeon benefited from nerve decompression surgery in various degrees. The collaborative selection criteria employed in this study may be replicable in clinical practice.
Insights
Occipital nerve decompression surgery significantly improved refractory occipital neuralgia symptoms. This study suggests collaborative selection criteria for surgical candidates, offering hope for patients with persistent headaches.
Area of Science:
- Neurosurgery
- Pain Management
- Headache Medicine
Background:
- Refractory occipital neuralgia (ON) management is challenging.
- Clear selection criteria for surgical intervention and optimal preoperative medical management are lacking.
Purpose of the Study:
- To evaluate the efficacy of occipital nerve decompression surgery for refractory ON.
- To assess the impact of preoperative medical and injectable therapies on surgical outcomes.
Main Methods:
- Prospective enrollment of 15 ON patients undergoing nerve decompression surgery.
- Preoperative trials included occipital nerve blocks (NB), preventive medications, and onabotulinum toxin (BTX).
- Outcomes measured: headache frequency, intensity, duration, and response to treatments at 12 months postoperatively.
Main Results:
- Postoperative headache frequency, intensity, and duration significantly decreased (p < 0.01).
- Median patient-reported ON headache resolution was 80%.
- All patients reported improvement in comorbid headache disorders and enhanced effectiveness of prior treatments.
Conclusions:
- Nerve decompression surgery provided significant benefit for refractory ON patients.
- Collaborative selection criteria used in this study are potentially replicable in clinical practice.
